Evidence map›Paper›PMID 34618605›Full record

ArticleAnnals of Saudi medicine

Mehmet Karabey, Hüseyin Can, Tülay Öncü Öner, Mert Döşkaya, Sedef Erkunt Alak, Aysu Değirmenci Döşkaya, Muhammet Karakavuk, Ahmet Efe Köseoğlu, Cemal Ün, Adnan Yüksel Gürüz and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Deciphering Host-Pathogen Interactions: Role ofPathogens (Basel, Switzerland) · 2025
    Review
  4. Enteric parasites and associated factors in cancer patients in Nepal.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Mehmet KarabeyFrom the Department of Medical Microbiology, Izmir Katip Celebi Universitesi, Izmir, Turkey.
Hüseyin CanFrom the Department of Biology, Ege Universitesi, Izmir, Turkey.
Tülay Öncü ÖnerFrom the Department of Bioengineering, Manisa Celal Bayar Universitesi, Manisa, Turkey.
Mert DöşkayaFrom the Department of Parasitology, Ege University, Izmir, Turkey.
Sedef Erkunt AlakFrom the Department of Biology, Ege Universitesi, Izmir, Turkey.
Aysu Değirmenci DöşkayaFrom the Department of Parasitology, Ege University, Izmir, Turkey.
Muhammet KarakavukFrom the Odemis Vocational School, Ege Universitesi, Izmir, Turkey.
Ahmet Efe KöseoğluFrom the Department of Biology, Ege Universitesi, Izmir, Turkey.
Cemal ÜnFrom the Department of Biology, Ege Universitesi, Izmir, Turkey.
Adnan Yüksel GürüzFrom the Department of Parasitology, Ege University, Izmir, Turkey.
Ahmet AlacacıoğluFrom the Department of Medical Oncology, Izmir Katip Celebi Universitesi, Izmir, Turkey.
Bayram PektaşFrom theızmir Atatürk Training and Research Hospital, Department of Microbiology,ızmir, Turkey.
Aytül GülFrom the Department of Bioengineering, Ege Universitesi, Izmir, Turkey.
Selçuk KayaFrom the Department of Medical Microbiology, Izmir Katip Celebi Universitesi, Izmir, Turkey.
Ayşegül Aksoy GökmenFrom the Department of Medical Microbiology, Izmir Katip Celebi Universitesi, Izmir, Turkey.ORCID 0000-0001-6407-4592
Ege University · TRIzmir Kâtip Çelebi University · TRManisa Celal Bayar University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectiveInvestigate the prevalence of

designCross-sectional.

settingTertiary care. PATIENTS AND

methodsStool samples were collected from adult patients with malignant solid tumors receiving chemotherapy and diarrhea.

main outcome measureThe prevalence of SAMPLE SIZE: 94

resultsThe prevalence was 2.1% (2/94), 5.3% (5/94), and 5.3% (5/94) as detected by Ziehl-Neelsen staining, real-time PCR and ELISA, respectively. The prevalence reached 8.5% (8/94) using all results obtained from the three methods. Among eight positive stool samples, four were positive by at least two different methods (Ziehl-Neelsen staining-ELISA or ELISA-real-time PCR) whereas the remaining four were positive by either ELISA or real-time PCR.

conclusionThese findings show the risk of cryptosporidiosis in cancer patients and the necessity to use at least two diagnostic methods during the diagnosis of cryptosporidiosis to reach more accurate and trustworthy results. LIMITATIONS: Further studies with a larger sample size are recommended. CONFLICT OF INTEREST: None.

Indexed as

CryptosporidiosisCryptosporidiumNeoplasmsAnimalsCross-Sectional StudiesDiarrheaHumans

Identifiers

PMID34618605
PMCPMC8497003
OpenAlexW3202500871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.